Keymed Biosciences Inc 2025 Annual Report with Sustainability Disclosures
Company: Keymed Biosciences Inc
Sector: Manufacturing
Country: China
Year: 2025
Type: Annual Report with Sustainability Disclosures
Pages: 205
The report covers Keymed's 2025 consolidated operations and includes a dedicated ESG Report covering the Company and all subsidiaries. Financially, revenue reached 716,313 RMB'000. ESG highlights include 19,589.12 tCO 2 e of Scope 1 and 2 emissions, 941.76 tCO 2 e of Scope 3 emissions, 1,625 employees and 100% safety-training coverage. The Board is identified as the highest ESG decision-making body.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.